EUCTR2012-003617-34-NL进行中（未招募）不适用
Pharmacokinetics and optimal dosage of caspofungin in critically illpatients with suspected invasive candidiasis. - Optimal dosage of caspofungin in critically ill.
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Treatment with caspofungin.
- •Admission to an ICU.
- •Age = 18 years.
- •Suspected invasive candidiasis.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 40
排除标准
- •Blood sampling not possible.
研究者
相似试验
已完成
4 期
Pharmacokinetics and optimal dosage of caspofungin in critically ill patients with suspected invasive candidiasis.Suspected invasive candidiasissuspected invasive fungal infection10017528NL-OMON40105niversitair Medisch Centrum Groningen20
进行中（未招募）
不适用
Pharmacokinetics of Caspofungin after one dose in patients with liver failure.The pharmacokinetics parameters of caspofungin will be studied for the patient admitted for alcoholic hepatitis or decompensated cirrhosis (Child-Pugh score 7-15).MedDRA version: 16.0Level: LLTClassification code 10024678Term: Liver failureSystem Organ Class: 100000004871EUCTR2013-002079-16-BEHospital Erasme
进行中（未招募）
不适用
Serum pharmacokinetics of Caspofungin in patients with liver failure.The patient admitted for alcoholic hepatitis or decompensated cirrhosis (Child-Pugh score of 10-15) presenting with invasive aspergillosis (proven or probable) and treated by caspofungin.MedDRA version: 14.1Level: LLTClassification code 10024678Term: Liver failureSystem Organ Class: 100000004871EUCTR2012-004031-23-BEHopital Erasme
进行中（未招募）
不适用
Pharmacocinétique de la caspofungine chez le patient brûlé - CASPO-BRULESPatients ayant des brûlures étendues et graves.MedDRA version: 8.1Level: PTClassification code 10006794Term: Burns classified according to extent of body surface involveEUCTR2007-006767-69-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
已完成
4 期
Pharmacokinetics of Caspofungin After One Dose in Patients With Liver FailureBacterial Infections and MycosesLiver DiseaseNCT01968395Erasme University Hospital20